APO Research
Talk to an analyst

APO RESEARCH · REPORT

RNA-Targeted Small Molecules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global RNA-Targeted Small Molecules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025190 pages

Choose your research edition.

Industry ResearchRNA-Targeted Small Molecules Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal RNA-Targeted Small Molecules Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal RNA-Targeted Small Molecules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RNA-Targeted Small Molecules Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal RNA-Targeted Small Molecules Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global RNA-Targeted Small Molecules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for RNA-Targeted Small Molecules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for RNA-Targeted Small Molecules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RNA-Targeted Small Molecules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for RNA-Targeted Small Molecules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of RNA-Targeted Small Molecules include Twentyeight-Seven Therapeutics, STORM Therapeutics, Skyhawk Therapeutics, Ribometrix, H3 Biomedicine, Gotham Therapeutics, Expansion Therapeutics, Epics Therapeutics and Arrakis Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global RNA-Targeted Small Molecules market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of RNA-Targeted Small Molecules and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents RNA-Targeted Small Molecules revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the RNA-Targeted Small Molecules market size, projected growth trends, production technologies, key applications, and end-use industries.

RNA-Targeted Small Molecules Segment by Company

Twentyeight-Seven Therapeutics

STORM Therapeutics

Skyhawk Therapeutics

Ribometrix

H3 Biomedicine

Gotham Therapeutics

Expansion Therapeutics

Epics Therapeutics

Arrakis Pharmaceuticals

Anima Biotech Inc.

Accent Therapeutics

RNA-Targeted Small Molecules Segment by Type

mRNA Translation Regulation

RNA Splicing Modification

Indirect RNA Targeting - Epitranscriptomics

Direct RNA Targeting

RNA-Targeted Small Molecules Segment by Application

Laboratories

Hospitals

Phamacy

RNA-Targeted Small Molecules Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA-Targeted Small Molecules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RNA-Targeted Small Molecules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA-Targeted Small Molecules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of RNA-Targeted Small Molecules in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global RNA-Targeted Small Molecules industry.

Chapter 3: Detailed analysis of RNA-Targeted Small Molecules companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RNA-Targeted Small Moleculesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global RNA-Targeted Small Molecules Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of mRNA Translation Regulation Table 3. Key Players of RNA Splicing Modification Table 4. Key Players of Indirect RNA Targeting - Epitranscriptomics Table 3. Key Players of Direct RNA Targeting Table 4. Global RNA-Targeted Small Molecules Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Laboratories Table 6. Key Players of Hospitals Table 7. Key Players of Phamacy Table 8. Global RNA-Targeted Small Molecules Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global RNA-Targeted Small Molecules Market Size by Region (2021-2026) & (US$ Million) Table 10. Global RNA-Targeted Small Molecules Market Share by Region (2021-2026) Table 11. Global RNA-Targeted Small Molecules Market Size by Region (2027-2032) & (US$ Million) Table 12. Global RNA-Targeted Small Molecules Market Share by Region (2027-2032) Table 13. RNA-Targeted Small Molecules Industry Trends Table 14. RNA-Targeted Small Molecules Industry Drivers Table 15. RNA-Targeted Small Molecules Industry Opportunities and Challenges Table 16. RNA-Targeted Small Molecules Industry Restraints Table 17. Global RNA-Targeted Small Molecules Revenue by Company (US$ Million) & (2021-2026) Table 18. Global RNA-Targeted Small Molecules Revenue Market Share by Company (2021-2026) Table 19. Global RNA-Targeted Small Molecules Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global RNA-Targeted Small Molecules Key Company Head Office and Area Served Table 21. Global RNA-Targeted Small Molecules Company, Product Type & Application Table 22. Global RNA-Targeted Small Molecules Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global RNA-Targeted Small Molecules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global RNA-Targeted Small Molecules Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global RNA-Targeted Small Molecules Market Size by Type (2021-2026) & (US$ Million) Table 27. Global RNA-Targeted Small Molecules Market Size by Type (2027-2032) & (US$ Million) Table 28. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2021-2026) Table 29. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2027-2032) Table 30. Global RNA-Targeted Small Molecules Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global RNA-Targeted Small Molecules Market Size by Application (2021-2026) & (US$ Million) Table 32. Global RNA-Targeted Small Molecules Market Size by Application (2027-2032) & (US$ Million) Table 33. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2021-2026) Table 34. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2027-2032) Table 35. Twentyeight-Seven Therapeutics Company Information Table 36. Twentyeight-Seven Therapeutics Business Overview Table 37. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product Portfolio Table 39. Twentyeight-Seven Therapeutics Recent Development Table 40. STORM Therapeutics Company Information Table 41. STORM Therapeutics Business Overview Table 42. STORM Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. STORM Therapeutics RNA-Targeted Small Molecules Product Portfolio Table 44. STORM Therapeutics Recent Development Table 45. Skyhawk Therapeutics Company Information Table 46. Skyhawk Therapeutics Business Overview Table 47. Skyhawk Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Skyhawk Therapeutics RNA-Targeted Small Molecules Product Portfolio Table 49. Skyhawk Therapeutics Recent Development Table 50. Ribometrix Company Information Table 51. Ribometrix Business Overview Table 52. Ribometrix RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Ribometrix RNA-Targeted Small Molecules Product Portfolio Table 54. Ribometrix Recent Development Table 55. H3 Biomedicine Company Information Table 56. H3 Biomedicine Business Overview Table 57. H3 Biomedicine RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. H3 Biomedicine RNA-Targeted Small Molecules Product Portfolio Table 59. H3 Biomedicine Recent Development Table 60. Gotham Therapeutics Company Information Table 61. Gotham Therapeutics Business Overview Table 62. Gotham Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Gotham Therapeutics RNA-Targeted Small Molecules Product Portfolio Table 64. Gotham Therapeutics Recent Development Table 65. Expansion Therapeutics Company Information Table 66. Expansion Therapeutics Business Overview Table 67. Expansion Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Expansion Therapeutics RNA-Targeted Small Molecules Product Portfolio Table 69. Expansion Therapeutics Recent Development Table 70. Epics Therapeutics Company Information Table 71. Epics Therapeutics Business Overview Table 72. Epics Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Epics Therapeutics RNA-Targeted Small Molecules Product Portfolio Table 74. Epics Therapeutics Recent Development Table 75. Arrakis Pharmaceuticals Company Information Table 76. Arrakis Pharmaceuticals Business Overview Table 77. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product Portfolio Table 79. Arrakis Pharmaceuticals Recent Development Table 80. Anima Biotech Inc. Company Information Table 81. Anima Biotech Inc. Business Overview Table 82. Anima Biotech Inc. RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Anima Biotech Inc. RNA-Targeted Small Molecules Product Portfolio Table 84. Anima Biotech Inc. Recent Development Table 85. Accent Therapeutics Company Information Table 86. Accent Therapeutics Business Overview Table 87. Accent Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Accent Therapeutics RNA-Targeted Small Molecules Product Portfolio Table 89. Accent Therapeutics Recent Development Table 90. North America RNA-Targeted Small Molecules Market Size by Type (2021-2026) & (US$ Million) Table 91. North America RNA-Targeted Small Molecules Market Size by Type (2027-2032) & (US$ Million) Table 92. North America RNA-Targeted Small Molecules Market Size by Application (2021-2026) & (US$ Million) Table 93. North America RNA-Targeted Small Molecules Market Size by Application (2027-2032) & (US$ Million) Table 94. North America RNA-Targeted Small Molecules Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America RNA-Targeted Small Molecules Market Size by Country (2021-2026) Table 96. North America RNA-Targeted Small Molecules Market Size by Country (2027-2032) Table 97. Europe RNA-Targeted Small Molecules Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe RNA-Targeted Small Molecules Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe RNA-Targeted Small Molecules Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe RNA-Targeted Small Molecules Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe RNA-Targeted Small Molecules Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe RNA-Targeted Small Molecules Market Size by Country (2021-2026) Table 103. Europe RNA-Targeted Small Molecules Market Size by Country (2027-2032) Table 104. China RNA-Targeted Small Molecules Market Size by Type (2021-2026) & (US$ Million) Table 105. China RNA-Targeted Small Molecules Market Size by Type (2027-2032) & (US$ Million) Table 106. China RNA-Targeted Small Molecules Market Size by Application (2021-2026) & (US$ Million) Table 107. China RNA-Targeted Small Molecules Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia RNA-Targeted Small Molecules Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia RNA-Targeted Small Molecules Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia RNA-Targeted Small Molecules Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia RNA-Targeted Small Molecules Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia RNA-Targeted Small Molecules Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia RNA-Targeted Small Molecules Market Size by Country (2021-2026) Table 114. Asia RNA-Targeted Small Molecules Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. RNA-Targeted Small Molecules Product Image Figure 2. Global RNA-Targeted Small Molecules Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global RNA-Targeted Small Molecules Market Share by Type: 2025 VS 2032 Figure 4. mRNA Translation Regulation Image Figure 5. RNA Splicing Modification Image Figure 6. Indirect RNA Targeting - Epitranscriptomics Image Figure 7. Direct RNA Targeting Image Figure 8. Global RNA-Targeted Small Molecules Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global RNA-Targeted Small Molecules Market Share by Application: 2025 VS 2032 Figure 10. Laboratories Image Figure 11. Hospitals Image Figure 12. Phamacy Image Figure 13. Global RNA-Targeted Small Molecules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 15. Global RNA-Targeted Small Molecules Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global RNA-Targeted Small Molecules Market Share by Players in 2025 Figure 18. Global Top 5 and 10 RNA-Targeted Small Molecules Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global RNA-Targeted Small Molecules Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2021-2032) Figure 22. Global RNA-Targeted Small Molecules Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2021-2032) Figure 24. North America RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 25. North America RNA-Targeted Small Molecules Market Share by Type (2021-2032) Figure 26. North America RNA-Targeted Small Molecules Market Share by Application (2021-2032) Figure 27. North America RNA-Targeted Small Molecules Market Share by Country (2021-2032) Figure 28. United States RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 29. Canada RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 30. Mexico RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 31. Europe RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 32. Europe RNA-Targeted Small Molecules Market Share by Type (2021-2032) Figure 33. Europe RNA-Targeted Small Molecules Market Share by Application (2021-2032) Figure 34. Europe RNA-Targeted Small Molecules Market Share by Country (2021-2032) Figure 35. Germany RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 36. France RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 37. U.K. RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 38. Italy RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 39. Russia RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 41. China RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 42. China RNA-Targeted Small Molecules Market Share by Type (2021-2032) Figure 43. China RNA-Targeted Small Molecules Market Share by Application (2021-2032) Figure 44. Asia RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 45. Asia RNA-Targeted Small Molecules Market Share by Type (2021-2032) Figure 46. Asia RNA-Targeted Small Molecules Market Share by Application (2021-2032) Figure 47. Asia RNA-Targeted Small Molecules Market Share by Country (2021-2032) Figure 48. Japan RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 49. South Korea RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 52. India RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 53. Australia RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa RNA-Targeted Small Molecules Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa RNA-Targeted Small Molecules Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa RNA-Targeted Small Molecules Market Share by Country (2021-2032) Figure 58. Brazil RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 59. South Africa RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 61. Turkey RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 62. Argentina RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 63. UAE RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 64. Egypt RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 65. Chile RNA-Targeted Small Molecules Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • mRNA Translation Regulation
  • RNA Splicing Modification
  • Indirect RNA Targeting - Epitranscriptomics
  • Direct RNA Targeting
Applications
  • Laboratories
  • Hospitals
  • Phamacy
Companies covered
  • Twentyeight-Seven Therapeutics
  • STORM Therapeutics
  • Skyhawk Therapeutics
  • Ribometrix
  • H3 Biomedicine
  • Gotham Therapeutics
  • Expansion Therapeutics
  • Epics Therapeutics
  • Arrakis Pharmaceuticals
  • Anima Biotech Inc.
  • Accent Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global RNA-Targeted Small Molecules Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 mRNA Translation Regulation
  5. 1.2.3 RNA Splicing Modification
  6. 1.2.4 Indirect RNA Targeting - Epitranscriptomics
  7. 1.2.5 Direct RNA Targeting
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global RNA-Targeted Small Molecules Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Laboratories
  11. 1.3.3 Hospitals
  12. 1.3.4 Phamacy
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global RNA-Targeted Small Molecules Growth Trends by Region
  15. 1.5.1 Global RNA-Targeted Small Molecules Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 RNA-Targeted Small Molecules Market Size by Region (2021-2026)
  17. 1.5.3 RNA-Targeted Small Molecules Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global RNA-Targeted Small Molecules Market Dynamics
  1. 2.1 RNA-Targeted Small Molecules Industry Trends
  2. 2.2 RNA-Targeted Small Molecules Industry Drivers
  3. 2.3 RNA-Targeted Small Molecules Industry Opportunities and Challenges
  4. 2.4 RNA-Targeted Small Molecules Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global RNA-Targeted Small Molecules Revenue by Company (2021-2026)
  2. 3.2 Global RNA-Targeted Small Molecules Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global RNA-Targeted Small Molecules Key Company Head office and Area Served
  4. 3.4 Global RNA-Targeted Small Molecules Company, Product Type & Application
  5. 3.5 Global RNA-Targeted Small Molecules Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global RNA-Targeted Small Molecules Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 RNA-Targeted Small Molecules Players Market Share by Revenue in 2025
  9. 3.6.3 2025 RNA-Targeted Small Molecules Tier 1, Tier 2, and Tier 3
4 RNA-Targeted Small Molecules Market by Type
  1. 4.1 Global RNA-Targeted Small Molecules Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global RNA-Targeted Small Molecules Market Size by Type (2021-2032)
  3. 4.3 Global RNA-Targeted Small Molecules Market Size Share by Type (2021-2032)
5 RNA-Targeted Small Molecules Market by Application
  1. 5.1 Global RNA-Targeted Small Molecules Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global RNA-Targeted Small Molecules Market Size by Application (2021-2032)
  3. 5.3 Global RNA-Targeted Small Molecules Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Twentyeight-Seven Therapeutics
  2. 6.1.1 Twentyeight-Seven Therapeutics Company Information
  3. 6.1.2 Twentyeight-Seven Therapeutics Business Overview
  4. 6.1.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product Portfolio
  6. 6.1.5 Twentyeight-Seven Therapeutics Recent Developments
  7. 6.2 STORM Therapeutics
  8. 6.2.1 STORM Therapeutics Company Information
  9. 6.2.2 STORM Therapeutics Business Overview
  10. 6.2.3 STORM Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 STORM Therapeutics RNA-Targeted Small Molecules Product Portfolio
  12. 6.2.5 STORM Therapeutics Recent Developments
  13. 6.3 Skyhawk Therapeutics
  14. 6.3.1 Skyhawk Therapeutics Company Information
  15. 6.3.2 Skyhawk Therapeutics Business Overview
  16. 6.3.3 Skyhawk Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Skyhawk Therapeutics RNA-Targeted Small Molecules Product Portfolio
  18. 6.3.5 Skyhawk Therapeutics Recent Developments
  19. 6.4 Ribometrix
  20. 6.4.1 Ribometrix Company Information
  21. 6.4.2 Ribometrix Business Overview
  22. 6.4.3 Ribometrix RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Ribometrix RNA-Targeted Small Molecules Product Portfolio
  24. 6.4.5 Ribometrix Recent Developments
  25. 6.5 H3 Biomedicine
  26. 6.5.1 H3 Biomedicine Company Information
  27. 6.5.2 H3 Biomedicine Business Overview
  28. 6.5.3 H3 Biomedicine RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 H3 Biomedicine RNA-Targeted Small Molecules Product Portfolio
  30. 6.5.5 H3 Biomedicine Recent Developments
  31. 6.6 Gotham Therapeutics
  32. 6.6.1 Gotham Therapeutics Company Information
  33. 6.6.2 Gotham Therapeutics Business Overview
  34. 6.6.3 Gotham Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Gotham Therapeutics RNA-Targeted Small Molecules Product Portfolio
  36. 6.6.5 Gotham Therapeutics Recent Developments
  37. 6.7 Expansion Therapeutics
  38. 6.7.1 Expansion Therapeutics Company Information
  39. 6.7.2 Expansion Therapeutics Business Overview
  40. 6.7.3 Expansion Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Expansion Therapeutics RNA-Targeted Small Molecules Product Portfolio
  42. 6.7.5 Expansion Therapeutics Recent Developments
  43. 6.8 Epics Therapeutics
  44. 6.8.1 Epics Therapeutics Company Information
  45. 6.8.2 Epics Therapeutics Business Overview
  46. 6.8.3 Epics Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Epics Therapeutics RNA-Targeted Small Molecules Product Portfolio
  48. 6.8.5 Epics Therapeutics Recent Developments
  49. 6.9 Arrakis Pharmaceuticals
  50. 6.9.1 Arrakis Pharmaceuticals Company Information
  51. 6.9.2 Arrakis Pharmaceuticals Business Overview
  52. 6.9.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product Portfolio
  54. 6.9.5 Arrakis Pharmaceuticals Recent Developments
  55. 6.10 Anima Biotech Inc.
  56. 6.10.1 Anima Biotech Inc. Company Information
  57. 6.10.2 Anima Biotech Inc. Business Overview
  58. 6.10.3 Anima Biotech Inc. RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Anima Biotech Inc. RNA-Targeted Small Molecules Product Portfolio
  60. 6.10.5 Anima Biotech Inc. Recent Developments
  61. 6.11 Accent Therapeutics
  62. 6.11.1 Accent Therapeutics Company Information
  63. 6.11.2 Accent Therapeutics Business Overview
  64. 6.11.3 Accent Therapeutics RNA-Targeted Small Molecules Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Accent Therapeutics RNA-Targeted Small Molecules Product Portfolio
  66. 6.11.5 Accent Therapeutics Recent Developments
7 North America
  1. 7.1 North America RNA-Targeted Small Molecules Market Size (2021-2032)
  2. 7.2 North America RNA-Targeted Small Molecules Market Size by Type
  3. 7.2.1 North America RNA-Targeted Small Molecules Market Size by Type (2021-2026)
  4. 7.2.2 North America RNA-Targeted Small Molecules Market Size by Type (2027-2032)
  5. 7.2.3 North America RNA-Targeted Small Molecules Market Share by Type (2021-2032)
  6. 7.3 North America RNA-Targeted Small Molecules Market Size by Application
  7. 7.3.1 North America RNA-Targeted Small Molecules Market Size by Application (2021-2026)
  8. 7.3.2 North America RNA-Targeted Small Molecules Market Size by Application (2027-2032)
  9. 7.3.3 North America RNA-Targeted Small Molecules Market Share by Application (2021-2032)
  10. 7.4 North America RNA-Targeted Small Molecules Market Size by Country
  11. 7.4.1 North America RNA-Targeted Small Molecules Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America RNA-Targeted Small Molecules Market Size by Country (2021-2026)
  13. 7.4.3 North America RNA-Targeted Small Molecules Market Size by Country (2027-2032)
  14. 7.4.4 North America RNA-Targeted Small Molecules Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe RNA-Targeted Small Molecules Market Size (2021-2032)
  2. 8.2 Europe RNA-Targeted Small Molecules Market Size by Type
  3. 8.2.1 Europe RNA-Targeted Small Molecules Market Size by Type (2021-2026)
  4. 8.2.2 Europe RNA-Targeted Small Molecules Market Size by Type (2027-2032)
  5. 8.2.3 Europe RNA-Targeted Small Molecules Market Share by Type (2021-2032)
  6. 8.3 Europe RNA-Targeted Small Molecules Market Size by Application
  7. 8.3.1 Europe RNA-Targeted Small Molecules Market Size by Application (2021-2026)
  8. 8.3.2 Europe RNA-Targeted Small Molecules Market Size by Application (2027-2032)
  9. 8.3.3 Europe RNA-Targeted Small Molecules Market Share by Application (2021-2032)
  10. 8.4 Europe RNA-Targeted Small Molecules Market Size by Country
  11. 8.4.1 Europe RNA-Targeted Small Molecules Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe RNA-Targeted Small Molecules Market Size by Country (2021-2026)
  13. 8.4.3 Europe RNA-Targeted Small Molecules Market Size by Country (2027-2032)
  14. 8.4.4 Europe RNA-Targeted Small Molecules Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China RNA-Targeted Small Molecules Market Size (2021-2032)
  2. 9.2 China RNA-Targeted Small Molecules Market Size by Type
  3. 9.2.1 China RNA-Targeted Small Molecules Market Size by Type (2021-2026)
  4. 9.2.2 China RNA-Targeted Small Molecules Market Size by Type (2027-2032)
  5. 9.2.3 China RNA-Targeted Small Molecules Market Share by Type (2021-2032)
  6. 9.3 China RNA-Targeted Small Molecules Market Size by Application
  7. 9.3.1 China RNA-Targeted Small Molecules Market Size by Application (2021-2026)
  8. 9.3.2 China RNA-Targeted Small Molecules Market Size by Application (2027-2032)
  9. 9.3.3 China RNA-Targeted Small Molecules Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia RNA-Targeted Small Molecules Market Size (2021-2032)
  2. 10.2 Asia RNA-Targeted Small Molecules Market Size by Type
  3. 10.2.1 Asia RNA-Targeted Small Molecules Market Size by Type (2021-2026)
  4. 10.2.2 Asia RNA-Targeted Small Molecules Market Size by Type (2027-2032)
  5. 10.2.3 Asia RNA-Targeted Small Molecules Market Share by Type (2021-2032)
  6. 10.3 Asia RNA-Targeted Small Molecules Market Size by Application
  7. 10.3.1 Asia RNA-Targeted Small Molecules Market Size by Application (2021-2026)
  8. 10.3.2 Asia RNA-Targeted Small Molecules Market Size by Application (2027-2032)
  9. 10.3.3 Asia RNA-Targeted Small Molecules Market Share by Application (2021-2032)
  10. 10.4 Asia RNA-Targeted Small Molecules Market Size by Country
  11. 10.4.1 Asia RNA-Targeted Small Molecules Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia RNA-Targeted Small Molecules Market Size by Country (2021-2026)
  13. 10.4.3 Asia RNA-Targeted Small Molecules Market Size by Country (2027-2032)
  14. 10.4.4 Asia RNA-Targeted Small Molecules Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa RNA-Targeted Small Molecules Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Type
  3. 11.2.1 South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa RNA-Targeted Small Molecules Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Application
  7. 11.3.1 South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa RNA-Targeted Small Molecules Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Country
  11. 11.4.1 South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa RNA-Targeted Small Molecules Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst